First ever medicine for crippling genetic kidney disease added to PBS

The Liberal National Government will list a new medicine for adults with genetic kidney disease on the Pharmaceutical Benefits Scheme (PBS), saving patients around $23,000 a year.   Jinarc® (tolvaptan) will be available through the PBS from 1 January 2019.   It is the first effective drug treatment for autosomal dominant polycystic kidney disease (ADPKD)…

Mental health support this holiday season

For many, Christmas and New Year is a time of celebration with family, friends and loved ones.   However, the end of year holiday season can also be a time when many people experience stress, anxiety, depression, or social isolation.   Over this period, I want to encourage those seeking help to visit the Head…